Lenvatinib + Pembrolizumab

Treatment used for 1 condition

Total Trials
15
Total Participants
5K
Avg Effectiveness
65%
Avg Safety Score
35%

Conditions Treated

Click on a condition to view detailed treatment information and clinical trial data.